Cold autoimmune hemolytic anemia
| Cold autoimmune hemolytic anemia | |
|---|---|
| Synonyms | Cold agglutinin disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fatigue, pallor, jaundice, dark urine, cold-induced acrocyanosis |
| Complications | Anemia, Raynaud's phenomenon, hemolytic crisis |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Autoimmune disease, often idiopathic or secondary to infections or other conditions |
| Risks | Infections, lymphoproliferative disorders |
| Diagnosis | Direct Coombs test, blood smear, cold agglutinin titer |
| Differential diagnosis | Warm autoimmune hemolytic anemia, paroxysmal cold hemoglobinuria, cryoglobulinemia |
| Prevention | N/A |
| Treatment | Avoidance of cold, rituximab, corticosteroids, plasmapheresis |
| Medication | N/A |
| Prognosis | Variable, depends on underlying cause and response to treatment |
| Frequency | Rare |
| Deaths | N/A |
Cold Autoimmune Hemolytic Anemia[edit]
Cold Autoimmune Hemolytic Anemia (CAHA) is a rare type of autoimmune hemolytic anemia (AIHA) characterized by the premature destruction of red blood cells (RBCs) at low temperatures. This condition is mediated by autoantibodies that bind to RBCs, leading to their destruction by the immune system.
Pathophysiology[edit]
In CAHA, the immune system produces cold agglutinins, which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the IgM class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the liver and spleen.
Symptoms[edit]
The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include:
Diagnosis[edit]
Diagnosis of CAHA involves several laboratory tests, including:
- Complete blood count (CBC) showing anemia
- Direct Coombs test (direct antiglobulin test) positive for complement
- Detection of cold agglutinins in the blood
- Blood smear showing agglutinated RBCs
Treatment[edit]
Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include:
- Avoiding exposure to cold temperatures
- Use of immunosuppressive drugs such as rituximab
- Plasmapheresis in severe cases
Prognosis[edit]
The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation.
See Also[edit]
References[edit]
- "Cold agglutinin disease".Hematology.2016;2016(1)
- 226-231.doi:10.1182/asheducation-2016.1.226.
- ,
Hoffbrand's Essential Haematology, 7th edition, Wiley-Blackwell, 2016, ISBN 978-1118408674,
